News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Rajah Vignesh
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/30/2023 |
4
| Rajah Vignesh (SVP & CHIEF MEDICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.
Txns:
| Granted 32,000 options to buy
@ $4.55, valued at
$145.6k
|
|
01/19/2023 |
4
| Rajah Vignesh (SVP & CHIEF MEDICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.
Txns:
| Granted 17,800 shares
@ $0 Granted 35,700 options to buy
@ $4.7, valued at
$167.8k
|
|
11/16/2022 |
4
| Rajah Vignesh (SVP & CMO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.
Txns:
| Bought 1,195 shares
@ $4.924, valued at
$5.9k
|
|
04/28/2022 |
4
| Rajah Vignesh (SVP & CMO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $9.51, valued at
$190.2k
|
|
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2020 |
4
| Rajah Vignesh (SVP & CMO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $53.88, valued at
$1.1M
|
|
12/04/2020 |
4
| Rajah Vignesh (SVP and CMO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.
Txns:
| Bought 1,464 shares
@ $45.74, valued at
$67k
Bought 233 shares
@ $51.03, valued at
$11.9k
|
|
06/24/2020 |
4
| Rajah Vignesh (SVP & CMO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $48.67, valued at
$1.9M
|
|
|
|